US6825216B1ExpiredUtility
Alkaloid that inhibits biosynthesis of microtoxins and method for screening for mycotoxin inhibitors
Est. expirySep 28, 2019(expired)· nominal 20-yr term from priority
C07D 295/185A61K 31/4453C12N 15/80
82
PatentIndex Score
16
Cited by
35
References
2
Claims
Abstract
The present invention provides an alkaloid compound that is an inhibitor of mycotoxin biosynthesis. The alkaloid is an alkenyl piperidine amide wherein the alkenyl is a C18 alkenyl with one or more double bonds. The alkaloid inhibits transcription of the fungus genes nor-1, tri5 and ipnA. The present invention further provides a method for identifying compounds, which inhibit biosynthesis of aflatoxin in Aspergillus spp. and deoxynivalenol in Gibberella spp. without inhibiting growth of the fungus in vitro.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A substantially pure compound isolated from Piper nigrum consisting essentially an alkenylene piperidine amide wherein the alkenylene is a C18 alkenylene with four double bonds.
2. A formulation which consists essentially of as an active ingredient an alkenylene piperidine amide isolated from Piper nigrum wherein the alkenyl is a C18 alkenylene with four double bonds, or its salt, or its ester, and one or more acceptable carriers, excipients or vehicles therefor for use in inhibiting mycotoxin biosynthesis in fungi.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.